Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
260 participants
OBSERVATIONAL
2018-01-02
2023-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transanal Versus Laparoscopic Total Mesorectal Excision: a Cohort
NCT05682794
Transanal Versus Laparoscopic Total Mesorectal Excision For Rectal Cancer
NCT03359616
Short-term Outcomes of Transanal Total Mesorectal Excision With Structured Training Curriculums in China
NCT05108753
Flexible Colonoscope Assisted Hybrid Transanal Total Mesorectal Resection (taTME)
NCT06380855
The Feasibility and Safety of No-scar Transanal Total Mesorectal Excision for Rectal Cancer
NCT02236884
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
transanal endoscopic ISR
transanal endoscopic ISR
perform ISR using laparoscopy through transanal port
traditional ISR
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
transanal endoscopic ISR
perform ISR using laparoscopy through transanal port
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists (ASA) score I to III
* A biopsy proven histological diagnosis of rectal carcinoma
* preoperative stage as (y) cT1-3N0-2M0
* lower margin of the tumor less than 5cm from the anus
* tumor diameter ≤5cm
Exclusion Criteria
* Synchronous rectal carcinoma
* History of colorectal cancer or other malignant tumors
* Clinical evidence of metastasis
* Emergency procedure
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Minimally Invasive Surgery Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ruijin Hospital
Shanghai, , China
Shanghai Minimally Invasive Surgery Center
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
taE-ISR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.